Literature DB >> 6197806

Liver pathology in transient neonatal hyperammonemia.

A Zimmermann, C Bachmann, I Högger, J Gehler, A Mielfried, E Mönch, H Peters.   

Abstract

Ultrastructural investigations have been performed on two cases of transient neonatal hyperammonaemia (TNH). This newly recognized metabolic disorder is chiefly characterized by severe hyperammonaemia in the postnatal period, a comatous state, absence of abnormal organic aciduria, normal activity of urea cycle enzymes and, usually, complete recovery. The aetiology is presently unknown. Electron microscopy uncovered rather congruent alterations of hepatocyte structure, with a wide spectrum of mitochondrial lesions, an increase of autophagous bodies with organelle remnants, and changes in the excretory apparatus. Thus, in contrast to some of the hereditary disorders of the urea cycle, no specific structural changes could be found in TNH. This finding is in line with the observation of normal activities of main urea enzymes in these cases, and indicates that a different biochemical system may be pathogenetically involved in TNH.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6197806     DOI: 10.1007/bf00695046

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histopathol        ISSN: 0174-7398


  18 in total

1.  Ornithinemia, hyperammonemia, and homocitrullinuria. A disease associated with mental retardation and possibly caused by defective mitochondrial transport.

Authors:  V Fell; R J Pollitt; G A Sampson; T Wright
Journal:  Am J Dis Child       Date:  1974-05

2.  Transient neonatal hyperammonaemia and herpes simplex infection.

Authors:  J Jaeken; H Devlieger; P Casaer; E Eggermont
Journal:  Lancet       Date:  1982-07-31       Impact factor: 79.321

3.  Transient hyperammonemia in an early preterm infant.

Authors:  J C Le Guennec; I A Qureshi; H Bard; J Y Siriez; J Letarte
Journal:  J Pediatr       Date:  1980-03       Impact factor: 4.406

4.  Mitochondrial abnormalities of liver in primary ornithine transcarbamylase deficiency.

Authors:  J M Shapiro; F Schaffner; H H Tallan; G E Gaull
Journal:  Pediatr Res       Date:  1980-05       Impact factor: 3.756

5.  Abnormalities of carbamyl phosphate synthetase and ornithine transcarbamylase in liver of patients with Reye's syndrome.

Authors:  F Sinatra; T Yoshida; M Applebaum; N J Masion Hoogenraad; P Sunshine
Journal:  Pediatr Res       Date:  1975-11       Impact factor: 3.756

6.  Transiently reduced activity of carbamyl phosphate synthetase and ornithine transcarbamylase in liver of children with Reye's syndrome.

Authors:  T Brown; G Hug; L Lansky; K Bove; A Scheve; M Ryan; H Brown; W K Schubert; J C Partin; J Lloyd-Still
Journal:  N Engl J Med       Date:  1976-04-15       Impact factor: 91.245

7.  Familial protein intolerance with deficient transport of basic amino acids. An analysis of 10 patients.

Authors:  M Kekomäki; J K Visakorpi; J Perheentupa; L Saxén
Journal:  Acta Paediatr Scand       Date:  1967-11

8.  Transient hyperammonemia of the preterm infant.

Authors:  R A Ballard; B Vinocur; J W Reynolds; R P Wennberg; A Merritt; L Sweetman; W L Nyhan
Journal:  N Engl J Med       Date:  1978-10-26       Impact factor: 91.245

9.  Hyperornithinemia, hyperammonemia, and homocitrullinuria. A new disorder of amino acid metabolism associated with myoclonic seizures and mental retardation.

Authors:  V E Shih; M L Efron; H W Moser
Journal:  Am J Dis Child       Date:  1969-01

10.  Asymptomatic hyperammonemia in patients receiving valproic acid.

Authors:  J V Murphy; K Marquardt
Journal:  Arch Neurol       Date:  1982-09
View more
  2 in total

1.  Mitochondrial abnormalities of liver in two children with citrullinaemia.

Authors:  S A Zamora; A Pinto; R B Scott; H G Parsons
Journal:  J Inherit Metab Dis       Date:  1997-08       Impact factor: 4.982

2.  Ultrastructural findings in citrullinaemia in Holstein-Friesian calves.

Authors:  P A Harper; P J Healy; J A Dennis; A B Martin
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.